K Wagner

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

K Wagner is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, K Wagner has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in K Wagner's work include HIV Research and Treatment (9 papers), Drug-Induced Adverse Reactions (4 papers) and HIV/AIDS Research and Interventions (4 papers). K Wagner is often cited by papers focused on HIV Research and Treatment (9 papers), Drug-Induced Adverse Reactions (4 papers) and HIV/AIDS Research and Interventions (4 papers). K Wagner collaborates with scholars based in United States, Italy and Egypt. K Wagner's co-authors include King K. Holmes, George W. Counts, R Amsel, Walter E. Stamm, E. Russell Alexander, Marvin Turck, Donald S. Burke, John R. Mascola, John G. McNeil and Henry G. Skelton and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

K Wagner

20 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes of the Acute Urethral Syndrome in Women

1980 339 citations Walter E. Stamm, K Wagner et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Wagner United States	13	678	495	396	341	174	20	1.2k
Kamnoosh Shahabi Canada	15	342 0.5×	389 0.8×	295 0.7×	297 0.9×	166 1.0×	24	1.1k
J. L. Vildé France	18	204 0.3×	553 1.1×	320 0.8×	130 0.4×	77 0.4×	39	1.0k
A. P. Fiddian United Kingdom	21	239 0.4×	1.2k 2.4×	423 1.1×	131 0.4×	35 0.2×	34	1.5k
Prameet M. Sheth Canada	22	1.0k 1.5×	470 0.9×	704 1.8×	760 2.2×	237 1.4×	62	1.9k
Vanni Borghi Italy	23	910 1.3×	557 1.1×	1.1k 2.7×	313 0.9×	242 1.4×	102	1.8k
Alain Lafeuillade France	24	1.2k 1.7×	368 0.7×	1.1k 2.7×	259 0.8×	89 0.5×	89	1.7k
Peggy Sue Weintrub United States	19	334 0.5×	485 1.0×	531 1.3×	177 0.5×	42 0.2×	38	1.2k
Joan Dragavon United States	25	785 1.2×	633 1.3×	854 2.2×	147 0.4×	83 0.5×	42	1.4k
Ronald E. Keeney United States	21	127 0.2×	1.4k 2.8×	325 0.8×	253 0.7×	84 0.5×	36	1.8k
Joaquín Burgos Spain	19	331 0.5×	670 1.4×	367 0.9×	148 0.4×	87 0.5×	82	1.2k

Countries citing papers authored by K Wagner

Since Specialization

Citations

This map shows the geographic impact of K Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Wagner more than expected).

Fields of papers citing papers by K Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Wagner. The network helps show where K Wagner may publish in the future.

Co-authorship network of co-authors of K Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of K Wagner. A scholar is included among the top collaborators of K Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Wagner. K Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blackford, Amanda L., et al.. (2018). Early Identification of Intracranial Hemorrhage Using a Predictive Nomogram. Oncology nursing forum. 45(2). 177–186. 1 indexed citations

Artenstein, Andrew W., Thomas C. VanCott, Karl Sitz, et al.. (1997). Mucosal Immune Responses in Four Distinct Compartments of Women Infected with Human Immunodeficiency Virus Type 1: A Comparison by Site and Correlation with Clinical Information. The Journal of Infectious Diseases. 175(2). 265–271. 57 indexed citations

Smith, Kenneth J., et al.. (1997). Preservation of Allergic Contact Dermatitis to Poison Ivy (Urushiol) in Late HIV Disease. Dermatology. 195(2). 145–149. 6 indexed citations

Smith, Kenneth J., Henry G. Skelton, Josef Yeager, et al.. (1997). Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease^*. Clinical and Experimental Dermatology. 22(3). 118–121. 40 indexed citations

Smith, Kenneth J., et al.. (1997). Pruritus in HIV-1 Disease: Therapy with Drugs Which May Modulate the Pattern of Immune Dysregulation. Dermatology. 195(4). 353–358. 25 indexed citations

Perfetto, Stephen P., Theresa E. Hickey, Patrick J. Blair, et al.. (1997). Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals. Cytometry. 30(1). 1–9. 24 indexed citations

Smith, Kenneth J., Henry G. Skelton, Josef Yeager, et al.. (1997). Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).. PubMed. 22(3). 118–23. 54 indexed citations

McDonald, R. A., R. Chung, K Wagner, et al.. (1997). Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. Journal of Virology. 71(3). 1871–1879. 40 indexed citations

Mascola, John R., S W Snyder, O. S. Weislow, et al.. (1996). Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 173(2). 340–348. 354 indexed citations

10.

Hickey, Theresa E., Patrick J. Blair, Stephen P. Perfetto, et al.. (1996). Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infection. The Journal of Immunology. 156(10). 4012–4017. 7 indexed citations

11.

Skillman, Donald R., Joseph L. Malone, Catherine F. Decker, et al.. (1996). Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Immunodeficiency Virus Type 1 Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity. The Journal of Infectious Diseases. 173(5). 1107–1114. 39 indexed citations

12.

Mapou, Robert L., Wendy Law, K Wagner, Joseph L. Malone, & Donald R. Skillman. (1996). Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals. Journal of Neuropsychiatry. 8(1). 74–81. 22 indexed citations

13.

Mascola, John R., Joost Louwagie, F. E. McCutchan, et al.. (1994). Two Antigenically Distinct Subtypes of Human Immunodeficiency Virus Type 1: Viral Genotype Predicts Neutralization Serotype. The Journal of Infectious Diseases. 169(1). 48–54. 147 indexed citations

14.

Japour, Anthony J., Jean Marie Arduino, Hammer Sm, et al.. (1994). Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group. Antimicrobial Agents and Chemotherapy. 38(2). 307–314. 53 indexed citations

15.

Murphy, Philip M., et al.. (1989). Cure of Bacille Calmette-Guerin Vaccination Abscesses with Erythromycin. Clinical Infectious Diseases. 11(2). 335–337. 8 indexed citations

16.

Wagner, K, et al.. (1989). Clinical Manifestations of Kingella kingae Infections: Case Report and Review. Clinical Infectious Diseases. 11(5). 776–782. 24 indexed citations

17.

Wagner, K, George W. Counts, King K. Holmes, et al.. (1981). Clinical Evaluation of Single-Dose Oral Bacampicillin or Ampicillin in Therapy of Uncomplicated Gonorrhea. Clinical Infectious Diseases. 3(1). 166–169. 3 indexed citations

18.

Wagner, K, Andrew D. Blair, George W. Counts, & K. K. Holmes. (1980). Pharmacological and in vitro evaluation of cyclacillin: assessment as potential single-dose therapy for treatment of Neisseria gonorrhoeae infection. Antimicrobial Agents and Chemotherapy. 17(1). 89–91. 1 indexed citations

19.

Stamm, Walter E., K Wagner, R Amsel, et al.. (1980). Causes of the Acute Urethral Syndrome in Women. New England Journal of Medicine. 303(8). 409–415. 339 indexed citations breakdown →

20.

Wagner, K & J Kösters. (1968). [Serological examinations into infectious bursitis in young pullets (Gumboro disease)].. PubMed. 81(23). 464–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact